Developments CytoDyn reports interim data from HIV leronlimab monotherapy trial CytoDyn (OTCQB:CYDY) reported interim data from its dose-escalating trial of leronlimab monotherapy for the treatment of HIV. Leronlimab is humanized monoclonal antibody that targets CCR5, a receptor by which HIV enters... August 14, 2019